Sen. Eric Schmitt notched a highlight this week he won't soon forget.

Russia's military hackers targeted home routers across 23 states. Here's what to do Trump unveils blue reflecting pool amid leak warnings Pink brings entire family in rare red carpet appearance as ...

If the money wasn’t astronomical, the Thunder would be thrilled to keep Dort. Wallace is coming on so fast, who knows if Dort ...

South Korea and China have agreed to their first expansion of bilateral air traffic rights since 2019, paving the way for additional passenger and cargo services as travel demand between the countries ...

What would it take for Alcoa Corp. to restart idled U.S. capacity? More certainty on the tariff front—but maybe not the expected kind. Speaking to analysts and investors on July 16 after Alcoa ...

Strength training does a body good — and that includes your heart. It’s the focus of Start TODAY’s June workout plan, called the Summer Strong Challenge. Anytime a person builds muscle, it boosts ...

FIFA's World Cup kicks off next week with six games being played right here in the South Bay. Businesses are preparing for an influx of fans, but are also strategizing to draw crowds into different ...

Zack Moss has gone from being a healthy inactive to leading the Bills’ running backs in playing time in the span of three ...

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred Three years after “Barbie,” Mattel returns to ...

DAYTON — An area of low pressure will develop and mature over the next two days. The low is forecast to slide over the Great Lakes and the warm front will lift over the Valley. This allows for warm, ...

A visual take on one of the biggest stories of the week. Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...